Best Cannabis Stocks — Rankings & Analysis
Data-driven rankings of the best cannabis stocks. Top 10 by market cap, revenue, and growth with live financial data from 94 tracked companies.
How We Rank Cannabis Stocks
Cannabismarketcap ranks cannabis stocks using objective, quantitative metrics sourced from public financial filings and market data. We do not assign subjective "buy" or "sell" ratings. Instead, we present the raw data across multiple dimensions so you can make your own informed decisions.
The rankings below are generated directly from our live database of 94 publicly traded cannabis companies. Data updates as new prices and financial filings are processed. Rankings are not investment recommendations — they are data-driven starting points for your own research.
We rank stocks across three key dimensions: Market Cap (company size and market valuation), Revenue (actual sales generated), and Revenue Growth (how fast the company is growing). Visit our full rankings page for 12 additional metrics including gross margin, P/S ratio, cash burn, and dilution.
Top 10 Cannabis Stocks by Market Cap
The largest cannabis companies by market capitalization. These are generally the most established operators with the broadest footprints and most institutional coverage.
| Ticker | Name | Sector | Price | Change | Market Cap | Revenue TTM | Margin | P/S |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals | Biotech | $202.37 | -0.12% | $12.19B | $4.16B | — | 2.89x |
| SMG | Scotts Miracle-Gro | Ancillary | $66.13 | +0.08% | $3.91B | $3.35B | 3098.2% | 1.16x |
| CURLF | Curaleaf Holdings | MSO | $2.36 | +2.83% | $1.80B | $0 | — | — |
| IIPR | Innovative Industrial Properties | REIT | $56.00 | -0.05% | $1.56B | $276.0M | — | 5.62x |
| GTBIF | Green Thumb Industries | MSO | $6.56 | +7.01% | $1.54B | $0 | — | — |
| TPB | Turning Point Brands | Ancillary | $77.53 | -0.42% | $1.49B | $463.1M | 5708.0% | 3.19x |
| TCNNF | Trulieve Cannabis | MSO | $6.40 | +4.92% | $1.22B | $0 | — | — |
| CRON | Cronos Group | LP | $2.65 | +0.76% | $990.3M | $146.6M | 4281.3% | 6.91x |
| MSOS | AdvisorShares Pure US Cannabis ETF | ETF | $5.04 | +1.00% | $973.9M | $0 | — | — |
| TLRY | Tilray Brands | LP | $6.64 | +0.45% | $793.4M | $858.3M | 2767.8% | 0.92x |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.
GREEN THUMB INDUS SUB VTG
Top 10 Cannabis Stocks by Revenue
Cannabis companies generating the most revenue in the trailing twelve months. Revenue is the most important fundamental metric for an industry where most companies are not yet profitable.
| Ticker | Name | Sector | Price | Change | Market Cap | Revenue TTM | Margin | P/S |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals | Biotech | $202.37 | -0.12% | $12.19B | $4.16B | — | 2.89x |
| SMG | Scotts Miracle-Gro | Ancillary | $66.13 | +0.08% | $3.91B | $3.35B | 3098.2% | 1.16x |
| TLRY | Tilray Brands | LP | $6.64 | +0.45% | $793.4M | $858.3M | 2767.8% | 0.92x |
| TPB | Turning Point Brands | Ancillary | $77.53 | -0.42% | $1.49B | $463.1M | 5708.0% | 3.19x |
| CGC | Canopy Growth | LP | $1.18 | +0.60% | $457.2M | $278.4M | 2584.6% | 1.64x |
| IIPR | Innovative Industrial Properties | REIT | $56.00 | -0.05% | $1.56B | $276.0M | — | 5.62x |
| VFF | Village Farms International | LP | $2.82 | +0.75% | $321.7M | $253.3M | 3349.1% | 1.32x |
| MAPS | WM Technology (Weedmaps) | Ancillary | $0.39 | -11.03% | $42.0M | $174.7M | 9494.4% | 0.24x |
| GRWG | GrowGeneration | Ancillary | $1.36 | +0.74% | $81.1M | $161.7M | 2675.6% | 0.51x |
| CRON | Cronos Group | LP | $2.65 | +0.76% | $990.3M | $146.6M | 4281.3% | 6.91x |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
Top 10 Cannabis Stocks by Revenue Growth
The fastest-growing cannabis companies by year-over-year revenue growth. High growth rates can indicate expanding market share, successful new market entry, or recent acquisitions. Verify that growth is organic rather than solely acquisition-driven.
| Ticker | Name | Sector | Revenue Growth YoY | Revenue TTM | Market Cap |
|---|
How to Choose the Best Cannabis Stocks
There is no single "best" cannabis stock — the right choice depends on your investment objectives, risk tolerance, and time horizon. Here is a framework for evaluating cannabis stocks across multiple dimensions:
For Conservative Investors: Focus on the largest companies by market cap with positive or near-positive cash flow. These companies have proven business models, broader analyst coverage, and generally more liquidity. Cannabis ETFs like MSOS and MJ offer diversified exposure with less single-stock risk.
For Growth Investors: Look at the revenue growth rankings and identify companies expanding fastest. Cross-reference with cash runway — fast-growing companies with limited cash may need to raise capital through dilutive offerings. A company growing revenue 30%+ with 18+ months of cash runway is in a strong position.
For Value Investors: Screen for low P/S ratios combined with positive gross margins and reasonable debt levels. Our valuation guide identifies the most undervalued cannabis stocks by multiple metrics. Low valuation alone is not sufficient — verify that the company has a viable path to profitability.
For Speculative Investors: Higher-risk picks may include penny stocks or small-cap companies with catalysts (new state licenses, international expansion, regulatory changes). Position sizing is critical — limit speculative positions to a small percentage of your portfolio.
Frequently Asked Questions
What is the best cannabis stock to buy?▾
There is no single 'best' cannabis stock — it depends on your risk tolerance, investment horizon, and strategy. The largest cannabis companies by market cap tend to be less volatile, while smaller companies may offer higher growth potential with more risk.
How often are these rankings updated?▾
Rankings on CannaCap update automatically as stock prices and financial data change. The data reflects the most recent trading session.
Should I buy cannabis stocks or ETFs?▾
ETFs like MSOS offer diversified exposure to the cannabis sector with less single-stock risk. Individual stocks offer higher potential returns but with concentrated risk. Many investors use a combination of both.
What metrics matter most for cannabis stocks?▾
Revenue growth, gross margin, cash runway, and Price-to-Sales ratio are the most important metrics for cannabis stocks. Most cannabis companies are not yet profitable, so traditional P/E ratios are less useful.
How many cannabis stocks are publicly traded?▾
CannaCap tracks 94 publicly traded cannabis companies across all sectors and exchanges.
Related Resources
Disclaimer: This guide is for informational purposes only and does not constitute financial advice. All data is sourced from our database and may not reflect real-time prices. Cannabis stocks are highly volatile and carry significant risk. Always conduct your own research and consult a licensed financial advisor before making investment decisions. Past performance is not indicative of future results.